Jun. 29 2009
Source Page: Building telecare in England. 21 p.Found: stakeholders through the Department of Health Telecare Policy Collaborative.
Correspondence Jan. 31 2024
Committee: Women and Equalities CommitteeFound: Correspondence from the Parliamentary Under Secretary of State, Department of Health and Social Care,
Dec. 07 2009
Source Page: New horizons: a shared vision for mental health. Incl. annexes. 100 p.Found: New horizons: a shared vision for mental health. Incl. annexes. 100 p.
Dec. 05 2007
Source Page: Valuing people now: from progress to transformation. Consultation paper. 89 p.Found: To help address this, the Office of Disability Issues, Department of Health, Department of Work and
Asked by: Preet Kaur Gill (Labour (Co-op) - Birmingham, Edgbaston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the Office for Health Improvement and Disparities has an alcohol policy team.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Public health policy to prevent and reduce alcohol related health harms is part of the Health Improvement Directorate, within the Office for Health Improvement and Disparities. There are approximately 157.7 full time equivalent people employed in the directorate. Resources are allocated according to priorities to collectively address common behavioural risk factors, which often cluster, such as smoking, obesity and diet related factors, low physical activity, alcohol, and drug use. The directorate also draws on cross-cutting policy, surveillance, and analytical and delivery specialists across the Department to support policy development, including on alcohol related harms.
Written Evidence Feb. 06 2024
Inquiry: Children’s social careFound: CSC0030 - Children’s social care School for Policy Studies, University of Bristol Written Evidence
Nov. 13 2007
Source Page: Policy appraisal and health: a guide from the Department of Health. 56 p.Found: Policy appraisal and health: a guide from the Department of Health. 56 p.
Asked by: Helen Hayes (Labour - Dulwich and West Norwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions her Department has had with the Department for Science, Innovation and Technology on funding for (a) the Lobular Moon Shot Project and (b) other research into lobular breast cancer.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department invests £1.3 billion per year into health research, with more spent on cancer than any other disease group, through the National Institute for Health and Care Research (NIHR). We work closely with UK Research and Innovation (UKRI) and the Medical Research Council (MRC), who are responsible for channelling a large proportion of the Department for Science, Innovation and Technology’s investments in this area. Our officials meet regularly to discuss a wide range of our investments, including into lobular and other breast cancers, to drive the maximum collective research impact on policy, practice, and individual lives. While research to understand the mechanisms of cancer, including lobular breast cancer, is largely funded through UKRI and the MRC, the NIHR invests in translational and implementation research to drive innovations into policy and practice.
Launched in 2023, the Lobular Moonshot Project is a high-level funding proposal and campaign to raise money to support the Institute for Cancer Research (ICR), with whom we meet regularly, to invest in fellowships and projects in lobular breast cancer. We are proud to have invested £29 million in the ICR and Royal Marsden NIHR Biological Research Centre in 2022, supporting their efforts to strengthen research into cancer, again including lobular breast cancer. This is complemented by wider investments into breast cancer research, for example, a £1.3 million project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening through mammography, such as lobular breast cancer. Our support to the NIHR Clinical Research Network has enabled the delivery of 10 further lobular breast-cancer related studies.
Additionally, the NIHR supports breast cancer research funded by research partners in the charity and public sectors through the NIHR’s Clinical Research Network (CRN). Over the last five years, the CRN has supported delivery of 10 lobular breast cancer-related studies conducted by other partners. While the NIHR cannot respond to direct solicitations for funding, instead commissioning on the basis of research excellence, we would welcome more applications from researchers on lobular breast cancer, including from the ICR. The NIHR funds research on cancer prevention, detection, diagnosis, treatment, and care, which saves lives.
Asked by: Ellie Reeves (Labour - Lewisham West and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help reduce (a) assessment and (b) diagnosis waiting times for ADHD.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
It is the responsibility of integrated care boards to make appropriate provision available, to meet the health and care needs of their local population, including access to attention deficit hyperactivity disorder (ADHD) assessments, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines. The NICE’s guidelines for ADHD diagnosis and management aim to improve the diagnosis of ADHD, as well as the quality of care and support people receive. The NICE’s guidelines do not recommend a maximum waiting time standard for ADHD diagnosis, either from referral for an assessment to receiving an assessment, a diagnosis, or a first contact appointment.
There is, at present, no single, established dataset that can be used to monitor waiting times for the assessment or treatment for ADHD nationally. The Department is exploring options to improve data collection and reporting on ADHD assessment waiting times, to help improve access to ADHD assessments in a timely way and in line with the NICE’s guideline. In support of this, the National Institute for Health and Care Research’s Policy Research Programme has commissioned a research project to provide insights into local ADHD diagnosis waiting time data collection.
NHS England is establishing a new ADHD taskforce alongside the Government, to improve care for people living with the condition. The new taskforce will bring together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD, and help provide a joined up approach in response to concerns around rising demand for assessments and support.
Alongside the work of the taskforce, NHS England has announced that it will continue to work with stakeholders to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape, and capture examples from local health systems who are trialling innovative ways of delivering ADHD services, to ensure best practice is captured and shared across the system.
Nov. 26 2008
Source Page: Housing, care, support: a guide to integrating housing-related support at a regional level. 53 p.Found: Housing, care, support: a guide to integrating housing-related support at a regional level. 53 p.